Feed Insights Top Reports Pricing

⌘K

06:50:30·1086d

SECFilingvia Quantisnow

SEC Form 10-Q filed by Accenture plc

ByQuantisnow·Wall Street's wire, on your screen.

ACN· Accenture plc

Real Estate

Plus alert sent

Quantisnow Plus members were alerted at 06:50:32 ET - 2.6s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment ACN files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACN (Accenture plc) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Chief Accounting Officer Burgum Melissa A was granted 112 units of Class A ordinary shares, increasing direct ownership by 1% to 8,579 units (SEC Form 4)
General Counsel/Corp Secretary Unruch Joel was granted 153 units of Class A ordinary shares, increasing direct ownership by 0.55% to 28,031 units (SEC Form 4)
Chief Leadership & HR Officer Clifford Katherine Lee was granted 98 units of Class A ordinary shares, increasing direct ownership by 2% to 6,531 units (SEC Form 4)
CEO-The Americas Walsh John F was granted 153 units of Class A ordinary shares, increasing direct ownership by 0.60% to 25,722 units (SEC Form 4)
Chair and CEO Sweet Julie Spellman was granted 216 units of Class A ordinary shares, increasing direct ownership by 1% to 16,235 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022